中基健康
(000972)
| 流通市值：31.47亿 | | | 总市值：31.47亿 |
| 流通股本：7.71亿 | | | 总股本：7.71亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 196,809,756.29 | 54,821,851.96 | 492,115,607.53 | 354,172,619.51 |
| 营业总成本 | 267,349,675.09 | 76,544,878.06 | 675,945,880.11 | 484,958,167.04 |
| 其他经营收益 | | | | |
| 营业利润 | -69,324,860.44 | -20,079,930.94 | -48,779,313.71 | -146,518,029.23 |
| 利润总额 | -69,513,916.66 | -20,266,150.6 | -51,770,910.16 | -148,301,256.89 |
| 净利润 | -68,191,633.75 | -20,374,945.59 | -56,032,745.96 | -150,986,842.99 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | -277,831.54 | - |
| 综合收益总额 | -68,191,633.75 | -20,374,945.59 | -56,310,577.5 | -150,986,842.99 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 552,650,249.85 | 709,043,794.82 | 768,531,386.69 | 785,749,773.11 |
| 非流动资产: | | | | |
| 非流动资产合计 | 443,586,277.95 | 452,699,988.56 | 453,449,656.59 | 462,531,880.3 |
| 资产总计 | 996,236,527.8 | 1,161,743,783.38 | 1,221,981,043.28 | 1,248,281,653.41 |
| 流动负债: | | | | |
| 流动负债合计 | 864,457,098.18 | 978,850,906.51 | 1,017,526,005.81 | 1,221,411,064.33 |
| 非流动负债: | | | | |
| 非流动负债合计 | 172,968,826.92 | 176,265,586.01 | 177,452,801.02 | 194,544,618.12 |
| 负债合计 | 1,037,425,925.1 | 1,155,116,492.52 | 1,194,978,806.83 | 1,415,955,682.45 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | -39,796,742.42 | 6,492,780.51 | 26,122,298.88 | -171,455,526.61 |
| 股东权益合计 | -41,189,397.3 | 6,627,290.86 | 27,002,236.45 | -167,674,029.04 |
| 负债和股东权益合计 | 996,236,527.8 | 1,161,743,783.38 | 1,221,981,043.28 | 1,248,281,653.41 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 216,397,748.6 | 55,273,315.17 | 665,188,171.84 | 339,147,918.43 |
| 经营活动现金流出小计 | 89,469,879.03 | 58,195,709.96 | 418,498,917.6 | 376,516,958.26 |
| 经营活动产生的现金流量净额 | 126,927,869.57 | -2,922,394.79 | 246,689,254.24 | -37,369,039.83 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 432,866.2 | - | 6,708,409.61 | 542,200 |
| 投资活动现金流出小计 | 10,671,732.08 | 6,506,860.27 | 57,048,996.89 | 24,956,400.89 |
| 投资活动产生的现金流量净额 | -10,238,865.88 | -6,506,860.27 | -50,340,587.28 | -24,414,200.89 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 8,564,100 | - | 219,080,000 | 219,080,000 |
| 筹资活动现金流出小计 | 137,289,165.24 | 21,473,217.1 | 267,315,968.47 | 212,753,425 |
| 筹资活动产生的现金流量净额 | -128,725,065.24 | -21,473,217.1 | -48,235,968.47 | 6,326,575 |
| 汇率变动对现金及现金等价物的影响 | -0.72 | -0.38 | 1.38 | 1.62 |
| 现金及现金等价物净增加额 | -12,036,062.27 | -30,902,472.54 | 148,112,699.87 | -55,456,664.1 |
| 期末现金及现金等价物余额 | 285,757,038.68 | 266,890,628.41 | 297,793,100.95 | 94,223,736.98 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -12,036,062.27 | - | 148,112,699.87 | - |